Report

This report highlights key programs, activities, and policies of HHS’ strategic approach to addressing social determinants of health, including early accomplishments to date and stories of the on-the-ground impact that these initiatives are making in people’s lives. These and other actions being taken by HHS, and across the federal government, as well as cross-sector initiatives at the com

This brief summarizes an expert convening focused on the child support program’s current ability and future potential to help address child poverty.Key Findings

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report summarizing lessons learned from using communities of practice (CoPs) to support state, Tribal, local, and territorial (STLT) public health agencies during the COVID-19 pandemic.

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) and the Office of the Assistant Secretary for Health (OASH), in partnership with Mathematica, are conducting a comprehensive study to identify promising practices aimed at reducing disparities in COVID-19 vaccination and testing, and policy options to promote equitable, routine vaccination.

To help the federal government and STLT jurisdictions better prepare for emergencies, there is a need to understand how prepared different jurisdictions are for various emergencies. However, assessing whether a jurisdiction is prepared for different emergencies is inherently complex and there is a lack of consensus among practitioners and scholars on how to approach preparedness measurement.

The evolution of pathogens to resist the drugs used to treat infections is an ongoing threat to public health, animal health, food production, and national security. Globally, a recent analysis estimated that 1.2 million deaths were caused by antibiotic-resistant (AR) bacteria in 2019, making this threat a leading cause of death for people of all ages worldwide.

A 2020 study examined the feasibility of using substance use disorder (SUD) patient intake assessment data as source of information for treatment planning.

In 2023, ASPE launched a research project to understand the impacts of COVID-19 on the clinical trial enterprise and identify key lessons learned.

We report findings of a study that described the emerging nonprofit pharmaceutical industry and its commercialization activities to enhance access to affordable and essential drugs, or resiliency in the supply chains of medical products.